This week's episode focuses on early-stage and locally advanced non-small cell lung cancer - staging, pathology, local and systemic therapy. Before we start, the usual caveat: the treatment landscape of NSCLC is changing FAST, which is exciting, but know that the boards run a few years behind. The big shifts since our last episode are the move to 9th-edition TNM staging and the arrival of four different perioperative chemo+immunotherapy regimens. Shout out to Dr. Bharathi Muthusamy for reviewing this episode to keep us current for 2026!
Podden och tillhörande omslagsbild på den här sidan tillhör
Sam and Karine. Innehållet i podden är skapat av Sam and Karine och inte av,
eller tillsammans med, Poddtoppen.
